Major Depressive Disorder
Get a quick, expert overview of the key issues surrounding best practices and current consensus on major depressive disorder (MDD). This concise resource by Drs. Roger S. McIntyre, Carola Rong, Mehala Subramaniapillai, and Yena Lee consolidates today's available information on this complex topic into one convenient resource, making it an ideal, easy-to-digest reference for both psychiatrists and primary care physicians.
- Covers genetics and epigenetics, brain structural abnormalities, cognition, neuroendocrine alterations, and inflammatory abnormalities as they relate to MDD.
- Contains chapters on psychiatric comorbidity, pharmacological treatments, neuromodulatory treatments, lifestyle interventions, internet-based/technology-based interventions, and glutamate alterations.
|Author Information||By Roger S McIntyre, M.D., FRCPC, Professor, University of Toronto, Department of Psychiatry and Pharmacology; Head, Toronto Western Hospital- UHN, Mood Disorders Psychopharmacology Unit, Toronto, Ontario, Canada ; Edited by Carola Rong, MD, BSc, University Health Network ; Mehala Subramaniapillai, MSc. and Yena Lee, MSc|
|Table of Content||
1 Genetics of Major Depressive Disorder
2 Epigenetics of Major Depressive Disorder
3 Brain Structural Abnormalities of Major Depressive Disorder
4 Cognition in Major Depressive Disorder
5 Neuroendocrine Alterations in Major Depressive Disorder
6 Inflammatory Abnormalities in Major Depressive Disorder
7 Psychiatric Comorbidity in Major Depressive Disorder
8 Pharmacological Treatment of Major Depressive Disorder
9 Neuromodulatory Treatment of Major Depressive Disorder
10 Lifestyle Interventions in Major Depressive Disorder
11 Internet-based/Technology-based Interventions in Major Depressive Disorder
12 Glutamate Alterations in Major Depressive Disorder
|Stock Status||In Stock|